MedPharm Appoints President & CEO

MedPharm has appointed Eugene Ciolfi as its president and chief executive officer, and he has also been appointed to the company's board.

Mr. Ciolfi is charged with driving MedPharm’s growth further downstream into commercial manfacturing and opening up additional markets based on the company’s unique performance modelling, formulation development and manufacturing expertise.

He joins MedPharm with over 25 years of experience in the development and manufacturing of pharmaceutical drug products in semi-solid, liquid and other, alternative dosage forms. His previous experience includes having served in a variety of manufacturing, commercial operations and general management positions at DPT Laboratories. Most recently, for the past two years, Mr. Ciolfi served as site head of Torrent Pharma’s FDA/DEA Class II-V approved non-sterile liquid and semi-solid development and manufacturing operation.

Andy Muddle, co-founder of MedPharm who has served as its chief executive officer for the past 19 years, will remain with the company in an ambassadorial role. 

Professor Marc Brown, co-founder and chief scientific officer said, "MedPharm’s unique position in the topical and transdermal formulation development arena, along with Gene’s know-how and experience, makes for a winning combination. I would like to congratulate him as he steps into his new role, and we look forward to supporting him as he expands MedPharm’s offering."

-----------------------------------------------------------------------

Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.